Pauls Matthew sold PTHS
December 10, 2025 · Form 4 insider transaction
Pauls Matthew sold 9,542 shares of Pelthos Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as gift and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
9,542
Price
$0.00
Total value
N/A
InsiderPauls Matthew
RoleOfficer, Director
SecurityCommon Stock
Transaction codeG: Gift
Transaction dateDecember 10, 2025
Filing dateDecember 12, 2025
Shares owned after1,074
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On December 10, 2025, the Reporting Person transferred 9,542 shares of Common Stock to GP 2024 Trust, U/A Dated, 12/20/2024, for no consideration. The Reporting Person is not a trustee and does not retain investment or voting control over the shares. Following the gift, the Reporting Person disclaims beneficial ownership of the shares held by the Trust and reports beneficial ownership herein only to the extent of any pecuniary interest, if any.